Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease M Rosini, E Simoni, R Caporaso, F Basagni, M Catanzaro, IF Abu, ... European journal of medicinal chemistry 180, 111-120, 2019 | 58 | 2019 |
Memantine derivatives as multitarget agents in Alzheimer’s disease G Marotta, F Basagni, M Rosini, A Minarini Molecules 25 (17), 4005, 2020 | 57 | 2020 |
Development of [18F] FAMTO: a novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands S Bongarzone, F Basagni, T Sementa, N Singh, C Gakpetor, V Faugeras, ... Nuclear medicine and biology 68, 14-21, 2019 | 34 | 2019 |
NRF2 and PPAR-γ pathways in oligodendrocyte progenitors: focus on ROS protection, mitochondrial biogenesis and promotion of cell differentiation C De Nuccio, A Bernardo, C Troiano, MS Brignone, M Falchi, A Greco, ... International Journal of Molecular Sciences 21 (19), 7216, 2020 | 33 | 2020 |
Eye-Light on Age-Related Macular Degeneration: Targeting Nrf2-Pathway as a Novel Therapeutic Strategy for Retinal Pigment Epithelium M Catanzaro, C Lanni, F Basagni, M Rosini, S Govoni, M Amadio Frontiers in Pharmacology 11, 844, 2020 | 28 | 2020 |
Targeting cytokine release through the differential modulation of Nrf2 and NF-κB pathways by electrophilic/non-electrophilic compounds F Fagiani, M Catanzaro, E Buoso, F Basagni, D Di Marino, S Raniolo, ... Frontiers in pharmacology 11, 1256, 2020 | 20 | 2020 |
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase ML Di Paolo, M Cervelli, P Mariottini, A Leonetti, F Polticelli, M Rosini, ... Journal of enzyme inhibition and medicinal chemistry 34 (1), 740-752, 2019 | 19 | 2019 |
Role of Fyn kinase inhibitors in switching neuroinflammatory pathways G Marotta, F Basagni, M Rosini, A Minarini Current medicinal chemistry 29 (27), 4738-4755, 2022 | 18 | 2022 |
Functionalized cannabinoid subtype 2 receptor ligands: fluorescent, PET, photochromic and covalent molecular probes F Basagni, M Rosini, M Decker ChemMedChem 15 (15), 1374-1389, 2020 | 18 | 2020 |
Lights and shadows of electrophile signaling: focus on the Nrf2-Keap1 pathway F Basagni, C Lanni, A Minarini, M Rosini Future Medicinal Chemistry 11 (7), 707-721, 2019 | 16 | 2019 |
Radiosynthesis, preclinical, and clinical positron emission tomography studies of carbon-11 labeled endogenous and natural exogenous compounds A Shegani, S Kealey, F Luzi, F Basagni, JM Machado, SD Ekici, ... Chemical Reviews 123 (1), 105-229, 2022 | 12 | 2022 |
Nature-inspired hybrids (NIH) improve proteostasis by activating nrf2-mediated protective pathways in retinal pigment epithelial cells A Koskela, F Manai, F Basagni, M Liukkonen, M Rosini, S Govoni, ... Antioxidants 11 (7), 1385, 2022 | 8 | 2022 |
A nature-inspired Nrf2 activator protects retinal explants from oxidative stress and neurodegeneration MG Rossino, R Amato, M Amadio, M Rosini, F Basagni, M Cammalleri, ... Antioxidants 10 (8), 1296, 2021 | 7 | 2021 |
Inhibition of β-Amyloid Aggregation in Alzheimer’s Disease: The Key Role of (Pro) electrophilic Warheads F Basagni, M Naldi, T Ginex, FJ Luque, F Fagiani, C Lanni, M Iurlo, ... ACS Medicinal Chemistry Letters 13 (11), 1812-1818, 2022 | 6 | 2022 |
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties F Basagni, JA Ortega, SM Bertozzi, A Armirotti, M Summa, R Bertorelli, ... European Journal of Medicinal Chemistry 261, 115803, 2023 | 4 | 2023 |
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs G Nordio, F Piazzola, G Cozza, M Rossetto, M Cervelli, A Minarini, ... Molecules 28 (17), 6329, 2023 | 4 | 2023 |
Polyamine–Drug Conjugates: Do They Boost Drug Activity? F Basagni, G Marotta, M Rosini, A Minarini Molecules 28 (11), 4518, 2023 | 4 | 2023 |
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets F Basagni, ML Di Paolo, G Cozza, L Dalla Via, F Fagiani, C Lanni, ... Molecules 28 (21), 7424, 2023 | 1 | 2023 |
Correction to “Radiosynthesis, Preclinical and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds” A Shegani, S Kealey, F Luzi, F Basagni, J do Mar Machado, SD Ekici, ... Chemical Reviews 123 (15), 9718-9718, 2023 | | 2023 |
Activation of Nrf2‐mediated protective pathways by nature‐inspired hybrids improves proteostasis in retinal pigment epithelial cells A Koskela, F Manai, F Basagni, M Liukkonen, M Rosini, S Govoni, ... Acta Ophthalmologica 100, 2022 | | 2022 |